フルテキストURL fulltext20211004-1.pdf
著者 Fukui, Yuko| Hayano, Satoru| Kawanabe, Noriaki| Wang, Ziyi| Shimada, Akira| Saito, Megumu K.| Asaka, Isao| Kamioka, Hiroshi|
キーワード iPS cell RPL5 cleft lip and palate chondrocyte Diamond-Blackfan Anemia
備考 This is an Accepted Manuscript of an article published by Wiley.
This is the peer reviewed version of the following article: [Fukui, Y, Hayano, S, Kawanabe, N, Wang, Z, Shimada, A, Saito, MK, et al. Investigation of the molecular causes underlying physical abnormalities in Diamond-Blackfan anemia patients with RPL5 haploinsufficiency. Pathology International. 2021; 1-11. https://doi.org/10.1111/pin.13168], which has been published in final form at [https://doi.org/10.1111/pin.13168]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-ArchivedVersions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wileyor by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked toWiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof bythird parties from platforms, services and websites other than Wiley Online Library must be prohibited.|
発行日 2021-9-29
出版物タイトル Pathology International
2021巻
出版者 Wiley
開始ページ 1
終了ページ 11
ISSN 1320-5463
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd
論文のバージョン author
DOI 10.1111/pin.13168
関連URL isVersionOf https://doi.org/10.1111/pin.13168
フルテキストURL fulltext20210428_3.pdf
著者 Shimada, Akira|
キーワード Down syndrome Acute myeloid leukemia Acute megakaryoblastic leukemia Transient abnormal myelopoiesis Acute lymphoblastic leukemia Solid tumor Cancer predisposition syndrome GATA1 Down syndrome critical region 1
発行日 2021-01-21
出版物タイトル Pediatric Hematology Oncology Journal
出版者 Elsevier
ISSN 24681245
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
DOI 10.1016/j.phoj.2021.01.001
関連URL isVersionOf https://doi.org/10.1016/j.phoj.2021.01.001
フルテキストURL fulltext.pdf
著者 Ishida, Hisashi| Iguchi, Akihiro| Aoe, Michinori| Nishiuchi, Ritsuo| Matsubara, Takehiro| Keino, Dai| Sanada, Masashi| Shimada, Akira|
キーワード leukemia pediatric acute myeloid leukemia molecular genetics precision medicine
発行日 2020-11
出版物タイトル Biomedical Reports
13巻
5号
出版者 Spandidos Publications
開始ページ 46
ISSN 2049-9434
NCID AA12610729
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン publisher
PubMed ID 32934818
DOI 10.3892/br.2020.1353
Web of Science KeyUT 000606302400012
関連URL isVersionOf https://doi.org/10.3892/br.2020.1353
JaLCDOI 10.18926/AMO/61215
フルテキストURL 74_6_545.pdf
著者 Tatebe, Yasuhisa| Kanamitsu, Kiichiro| Kanzaki, Hirotaka| Ishida, Hisashi| Fujiwara, Kaori| Washio, Kana| Kitamura, Yoshihisa| Sendo, Toshiaki| Shimada, Akira| Tsukahara, Hirokazu|
抄録 Polymorphisms in methotrexate transporter pathways have been associated with methotrexate toxicities and clearance. Recent genome-wide association studies have revealed that the SLCO1B1 T521C variant is associated with methotrexate elimination. We present a case of a pediatric patient with acute lymphoblastic leukemia who suffered from persistently high plasma methotrexate concentrations and acute kidney injuries after the admin-istration of a medium dose of methotrexate. Subsequent genetic analysis showed that he was a carrier of dys-functional genetic variants associated with methotrexate clearance. This case highlights that polymorphisms of methotrexate transporter pathways can adversely affect methotrexate elimination in a clinically significant manner.
キーワード methotrexate polymorphism drug elimination acute kidney injury acute lymphoblastic leukemia
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2020-12
74巻
6号
出版者 Okayama University Medical School
開始ページ 545
終了ページ 550
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 33361876
Web of Science KeyUT 000601203600012
NAID 120006948942
フルテキストURL fulltext.pdf
著者 Oyama, Takanori| Noda, Takuo| Washio, Kana| Shimada, Akira|
キーワード growing teratoma syndrome immature teratoma ovarian tumor pediatric
発行日 2020-09-18
出版物タイトル Medicine
99巻
38号
出版者 Lippincott, Williams & Wilkins
開始ページ e22297
ISSN 0025-7974
NCID AA00728867
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 the Author(s).
論文のバージョン publisher
PubMed ID 32957389
DOI 10.1097/MD.0000000000022297
Web of Science KeyUT 000579298600086
関連URL isVersionOf https://doi.org/10.1097/MD.0000000000022297
JaLCDOI 10.18926/AMO/55208
フルテキストURL 71_3_249.pdf
著者 Washio, Kana| Muraoka, Michiko| Kanamitsu, Kiichiro| Oda, Megumi| Shimada, Akira|
抄録  We diagnosed a female infant with Langerhans cell histiocytosis (LCH) who was refractory to conventional chemotherapy. She showed refractory inflammation that was complicated with hemophagocytic lymphohistiocytosis (HLH) during LCH chemotherapy; therefore, we changed the protocol to HLH2004 (dexamethasone, cyclosporine A and VP16). However, there were no signs of hematological recovery. We therefore performed cord blood transplantation with reduced-intensity conditioning, and she achieved complete remission for over 2 years. As salvage therapy for refractory LCH, hematopoietic stem cell transplantation may be a good therapeutic choice, especially when LCH is complicated with HLH.
キーワード langerhans cell histiocytosis (LCH) hemophagocytic lymphohistiocytosis (HLH) hematopoietic stem cell transplantation (HSCT) reduced-intensity conditioning (RIC) refractory
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2017-06
71巻
3号
出版者 Okayama University Medical School
開始ページ 249
終了ページ 254
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2017 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 28655945
著者 Iwasaki, Yuka| Nishiuchi, Rituo| Aoe, Michinori| Takahashi, Takahide| Watanabe, Hirokazu| Tokorotani, Chiho| Kikkawa, Kiyoshi| Shimada, Akira|
発行日 2017-02
出版物タイトル Acta Medica Okayama
71巻
1号
資料タイプ 学術雑誌論文
JaLCDOI 10.18926/AMO/54829
JaLCDOI 10.18926/AMO/54815
フルテキストURL 70_6_503.pdf
著者 Kanazawa, Yui| Yamashita, Yuka| Fujiwara, Mitsuhiro| Muraoka, Michiko| Washio, Kana| Kanamitsu, Kiichiro| Ishida, Hisashi| Nakano, Takae| Yamada, Miho| Horibe, Keizo| Tanaka, Takehiro| Yoshino, Tadashi| Shimada, Akira|
抄録 Childhood anaplastic large cell lymphoma (ALCL) accounts for approx. 10–30 of cases of non-Hodgkin lymphoma, and the ALCL99 study reported 60–75 disease-free survival; however, a relatively high relapse rate was observed (25–30 ). We report 2 patients with Stage III ALCL who relapsed 6–18 months after the end of ALCL99 chemotherapy. A retrospective molecular analysis identified the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) fusion gene in the first diagnostic bone marrow samples taken from both patients. However, antibodies against the ALK protein appeared to be relatively low in the serum of both patients (×100 and ×750). An increase in chemotherapy intensity may be beneficial if Stage III ALCL patients are shown to be NPM-ALK chimera-positive in the first diagnostic bone marrow sample.
キーワード ALCL NPM-ALK fusion lymphoma
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2016-12
70巻
6号
出版者 Okayama University Medical School
開始ページ 503
終了ページ 506
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 28003677
JaLCDOI 10.18926/AMO/52408
フルテキストURL 68_2_119.pdf
著者 Takeda, Akiko| Shimada, Akira| Hamamoto, Kazuko| Yoshino, Syuuji| Nagai, Tomoko| Fujii, Yousuke| Yamada, Mutsuko| Nakamura, Yoshimi| Watanabe, Toshiyuki| Watanabe, Yuki| Yamamoto, Yuko| Sakakibara, Kanae| Oda, Megumi| Morishima, Tsuneo|
抄録 Acute megakaryocytic leukemia (AMKL) with t(1;22)(p13;q13) is a distinct category of myeloid leukemia by WHO classification and mainly reported in infants and young children. Accurate diagnosis of this type of AMKL can be difficult, because a subset of patients have a bone marrow (BM) blast percentage of less than 20% due to BM fibrosis. Therefore, it is possible that past studies have underestimated this type of AMKL. We present here the case of a 4-month-old female AMKL patient who was diagnosed by presence of the RBM15-MKL1 (OTT-MAL) fusion transcript by RT-PCR. In addition, we monitored RBM15-MKL1 fusion at several time points as a marker of minimal residual disease (MRD), and found that it was continuously negative after the first induction chemotherapy even by nested RT-PCR. Detection of the RBM15-MKL1 fusion transcript thus seems to be useful for accurate diagnosis of AMKL with t(1;22)(p13;q13). We recommend that the RBM15-MKL1 fusion transcript be analyzed for all suspected AMKL in infants and young children. Furthermore, monitoring of MRD using this fusion transcript would be useful in treatment of AMKL with t(1;22)(p13;q13).
キーワード AMKL infant RBM15-MKL1 OTT-MAL
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2014-04
68巻
2号
出版者 Okayama University Medical School
開始ページ 119
終了ページ 123
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2014 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 24743787
Web of Science KeyUT 000334652700007